# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-25-020826
Filing Date
2025-02-05
Accepted
2025-02-05 16:09:32
Documents
155
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | d865574d10k.htm iXBRL | 10-K | 3772452
2 | EX-10.8 | d865574dex108.htm | EX-10.8 | 145583
3 | EX-10.20 | d865574dex1020.htm | EX-10.20 | 145341
4 | EX-10.23 | d865574dex1023.htm | EX-10.23 | 58966
5 | EX-19 | d865574dex19.htm | EX-19 | 89428
6 | EX-21 | d865574dex21.htm | EX-21 | 7737
7 | EX-23 | d865574dex23.htm | EX-23 | 2277
8 | EX-31.1 | d865574dex311.htm | EX-31.1 | 10361
9 | EX-31.2 | d865574dex312.htm | EX-31.2 | 10330
10 | EX-32 | d865574dex32.htm | EX-32 | 4353
16 | GRAPHIC | g865574g0127165931745.jpg | GRAPHIC | 2258
17 | GRAPHIC | g865574g67r24.jpg | GRAPHIC | 109421
| Complete submission text file | 0001193125-25-020826.txt |  | 20049274

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
11 | XBRL TAXONOMY EXTENSION SCHEMA | teva-20241231.xsd | EX-101.SCH | 159036
12 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | teva-20241231_cal.xml | EX-101.CAL | 91737
13 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | teva-20241231_def.xml | EX-101.DEF | 905195
14 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | teva-20241231_lab.xml | EX-101.LAB | 1017107
15 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | teva-20241231_pre.xml | EX-101.PRE | 976879
158 | EXTRACTED XBRL INSTANCE DOCUMENT | d865574d10k_htm.xml | XML | 3837045

Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020
Business Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020 972 (3) 914-8213
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-16174 | Film No.: 25593342
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)